Robert E. Dudley Clarus Therapeutics Holdings, Inc. (CRXT) insider trading activity

CRXT Quotes by TradingView

Robert E. Dudley is Chief Executive Officer of Clarus Therapeutics Holdings, Inc.. Currently has a direct ownership of 139,566 shares of CRXT, which is worth approximately $4,186. The most recent transaction as insider was on Dec 12, 2021, when has been sold 135,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 140K
0% 3M change
0% 12M change
Total Value Held $4,186

Robert E. Dudley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 12 2021
BUY
Grant, award, or other acquisition
-
135,000 Added 49.17%
139,566 Common Stock
Sep 09 2021
BUY
Grant, award, or other acquisition
-
4,566 Added 50.0%
4,566 Common Stock
RED

Robert E. Dudley

Chief Executive Officer
Northbrook, IL

Track Institutional and Insider Activities on CRXT

Follow Clarus Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRXT shares.

Notify only if

Insider Trading

Get notified when an Clarus Therapeutics Holdings, Inc. insider buys or sells CRXT shares.

Notify only if

News

Receive news related to Clarus Therapeutics Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRXT